Clinical trial
Valproic Acid in Treating Patients With Kaposi's Sarcoma
NCT00075777 · AIDS Malignancy Consortium, Other · Completed
Key facts
| NCT number | NCT00075777 |
|---|---|
| Title | Valproic Acid in Treating Patients With Kaposi's Sarcoma |
| Official title | A Pilot Trial Of Valproic Acid In Patients With Kaposi's Sarcoma |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH The Emmes Company, LLC Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | valproic acid |
| Enrollment | 19 |
| Start date | Feb 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Jan 13, 2004 |
| Last update posted | Aug 29, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: